Breast cancer and obesity, a dangerous relation;Cancerdu sein et obeśité, une liaison dangereuse

Revue Medicale Suisse

Volumn 8, Issue 342, 2012, Pages 1101-1104

  Zaman, K ^a   Bodmer, A ^b   Pralong, F ^a   Castiglione Gertsch, M ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Genesupport Centre du Sein   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; DIET THERAPY; DISEASE ASSOCIATION; HEALTH PROMOTION; HUMAN; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POSTMENOPAUSE; REVIEW; SYSTEMIC THERAPY; WEIGHT GAIN; WEIGHT REDUCTION; BIOLOGICAL MODEL; BODY WEIGHT; BREAST TUMOR; CLINICAL PROTOCOL; FEMALE; PHYSIOLOGY; PROGNOSIS; RISK FACTOR; STANDARD;

ANTINEOPLASTIC PROTOCOLS; BODY WEIGHT; BREAST NEOPLASMS; FEMALE; HUMANS; MODELS, BIOLOGICAL; OBESITY; PROGNOSIS; RISK FACTORS;

EID: 84863920541     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Barnett GC, Shah M, Redman K, et al. Risk factors for the incidence of breast cancer: Do they affect survival from the disease? J Clin Oncol 2008;26:3310-6.
2. Food, Nutrition, Physical activity, and the prevention of cancer: A global perspective. Washington DC: AICR, 2007.
3. www.oecdorg/search
4. Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M. The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence. Maturitas 2009;64:80-5.
5. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78. (Pubitemid 351232031)
6. La Vecchia C, Negri E, Franceschi S, et al. Body mass index and post-menopausal breast cancer: An age-specific analysis. Br J Cancer 1997;75:441-4. (Pubitemid 27051064)
7. Eichholzer M, Schmid SM, Bovey F, et al. Impact of overweight and obesity on postmenopausal breast cancer: Analysis of 20-year data from Switzerland. Arch Gynecol Obstet 2012;285:797-803.
8. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: Findings from the European Prospective Investigation into Cancer and nutrition (EPIC). Int J Cancer 2004;111:762-71. (Pubitemid 39062901)
9. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38. (Pubitemid 36459468)
10. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: Systematic review and meta-analysis. Breast Cancer Res Treat 2010;123:627-35.
11. Sparano JA, Wang M, Martino S, Eastern Cooperative Oncology Group; Southwest Oncology Group; Cancer and Leukemia Group B; North Central Cancer Treatment Group. Obesity at diagnosis is associated with inferior outcomes in hormone receptor positive breast cancer. San Antonio Breast Cancer Symposium 2010; abstract S2-1.
12. Lu Y, Ma H, Malone KE, et al. Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol 2011;29:3358-65.
13. Conroy SM, Maskarinec G, Wilkens LR, et al. Obesity and breast cancer survival in ethnically diverse postmenopausal women: The Multiethnic cohort study. Breast Cancer Res Treat 2011;129:565-74.
14. Hepp P, Rack B, Annecke K, et al. Mulivariate analyzsis of obesity and disease free survival in patients with nodal positive primary breast cancer - The ADEBAR Trial. San Antonio Breast Cancer Symposium 2010; abstract S2.
15. Sestak I, Distler W, Forbes JF, et al. Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: An exploratory analysis from the ATAC trial. J Clin Oncol 2010;28:3411-5.
16. Pfeiler G, Konigsberg R, Fesl C, et al. Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial. J Clin Oncol 2011;29:2653-9.
17. Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes - dealing with the diversity of breast cancer: Highlights of the St. Gallen International expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol 2011;22:1736-47.
18. Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: The Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 2007;298:289-98. (Pubitemid 47080483)
19. Chlebowski RT, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's intervention nutrition study. J Natl Cancer Inst 2006;98:1767-76. (Pubitemid 46017928)
20. Yerushalmi R, Dong B, Chapman JW, et al. Impact of a change of body mass index (BMI) on outcome following adjuvant endocrine therapy, chemotherapy, or trastuzumab for breast cancer. American Society of Clinical Oncology Annual Meeting 2011; abstract 513.
21. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005;23:1370-8.
22. Rack B, Andergassen U, Neugebauer J, al. The German SUCCESS C Study - The First European Lifestyle Study on Breast Cancer. Breast Care (Basel) 2010;5:395-400.
23. Sung MK, Yeon JY, Park SY, Park JH, Choi MS. Obesity-induced metabolic stresses in breast and colon cancer. Ann N Y Acad Sci 2011;1229:61-8.
24. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: New perspectives. Annu Rev Med 2010;61:301-16.
25. Goodwin PJ, Ennis M, Pritchard KI, et al. Insulin- and obesity-related variables in early-stage breast cancer: Correlations and time course of prognostic associations. J Clin Oncol 2012;30:164-71.
26. Macis D, Gandini S, Guerrieri-Gonzaga A, et al. Prognostic effect of circulating adiponectin in a randomized 2x2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol 2012;30:151-7.
27. Guo S, Liu M, Wang G, Torroella-Kouri M, Gonzalez-Perez RR. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta 2012;1825:207-22.
28. Lohsiriwat V, Curigliano G, Rietjens M, Goldhirsch A, Petit JY. Autologous fat transplantation in patients with breast cancer: «Silencing» or «fueling» cancer recurrence? Breast 2011;20:351-7.
29. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007;14:189-206. (Pubitemid 47242622)
30. Sjostrom L, Gummesson A, Sjostrom CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): A prospective, controlled intervention trial. Lancet Oncol 2009;10:653-62.
31. Wee CC, McCarthy EP, Davis RB, Phillips RS. Obesity and breast cancer screening. J Gen Intern Med 2004;19:324-31.
32. Deglise C, Bouchardy C, Burri M, et al. Impact of obesity on diagnosis and treatment of breast cancer. Breast Cancer Res Treat 2010;120:185-93.
33. Griggs JJ, Sorbero ME, Lyman GH. Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 2005;165:1267-73. (Pubitemid 40989591)